- Condition: Hepatitis B
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620; Drug: Multiple Ascending Dose (MAD) Cohorts GS-9620
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified December 2011 - Condition: Herpes Labialis
Intervention: Drug: acyclovir/hydrocortisone cream
Sponsors: Meda Pharmaceuticals; Meda Pharmaceuticals; TKL Research, Inc.
Recruiting - verified April 2012 - Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Zoster Disease
Intervention: Other: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
Sponsors: Ohio State University; Ohio State University
Completed - verified January 2012 - Conditions: Herpes Zoster; Shingles
Interventions: Biological: Zoster Vaccine Live (AMP); Biological: Zoster Vaccine Live
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Varicella Zoster
Intervention: Drug: Zostavax (varicella zoster virus) vaccine
Sponsors: Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation
Recruiting - verified January 2012 - Condition: Herpes Zoster
Intervention: Behavioral: Education
Sponsors: New York University School of Medicine; New York University School of Medicine; Merck
Completed - verified March 2012 - Condition: Herpes
Interventions: Other: Versabase gel with sarracenia purpurea 20% liquid extract; Other: placebo (versabase gel only)
Sponsors: Naturopaths International; Naturopaths International
Completed - verified November 2011 - Conditions: Atopic Dermatitis; Eczema Herpeticum
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; GlaxoSmithKline
Recruiting - verified March 2012 - Conditions: Castleman Disease; Castleman's Disease; Giant Lymph Node Hyperplasia
Interventions: Drug: Zidovudine; Drug: Tocilizumab; Drug: Valganciclovir
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified July 2011 - Condition: Herpes Simplex Type II
Interventions: Drug: Tenofovir; Drug: placebo gel; Drug: tenofovir disoproxil fumarate (TDF); Drug: placebo tablets
Sponsors: University of Washington; University of Washington; CONRAD; Gilead Sciences
Recruiting - verified March 2012 - Conditions: KSHV Inflammatory Cytokine Syndrome (KICS); KSHV; HHV-8
Interventions: Drug: Zidovudine/Valgancyclovir; Drug: Rituximab/Liposoma Doxorubicin
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Atopic Dermatitis; Eczema Herpeticum; Herpes Simplex Infections; Eczema Vaccinatum
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Jewish Health; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2011 - Condition: Recurrent Herpes Labialis
Interventions: Drug: NB-001; Drug: Vehicle
Sponsors: NanoBio Corporation; NanoBio Corporation
Completed - verified January 2012 - Condition: Recurrent Herpes Simplex Labialis
Intervention: Drug: Vehicle versus NB-001
Sponsors: NanoBio Corporation; NanoBio Corporation
Completed - verified January 2012 - Condition: Shingles
Intervention: Biological: ZOSTAVAX
Sponsors: Emory University; Emory University; National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting - verified April 2012 - Conditions: Dermatologic Complications; Pain; Viral Infection
Interventions: Other: scrambler therapy; Other: questionnaire administration; Procedure: dermatologic complications management/prevention
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: Oral Herpes Simplex
Interventions: Drug: BTL TML HSV; Drug: Matching placebo
Sponsors: Beech Tree Labs, Inc.; Beech Tree Labs, Inc.; Norwich Clinical Research Associates LTD
Recruiting - verified January 2012 - Condition: Immunity; Defect Due to Antibody or Cell Mediated Immune Defect
Intervention:
Sponsors: Columbia University; Columbia University; Merck
Recruiting - verified August 2011 - Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Zoster
Intervention: Biological: Zoster Vaccine, Live
Sponsors: Merck; Merck; University of Colorado, Denver; Duke University
Recruiting - verified May 2012 - Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Matching placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Herpes Labialis
Interventions: Drug: onabotulinumtoxinA; Other: Bacteriostatic normal saline
Sponsors: DeNova Research; DeNova Research; Allergan
Recruiting - verified June 2011 - Conditions: LAD-1; DOCK8; MonoMAC
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster in HIV-infected Subjects
Interventions: Biological: Herpes Zoster Vaccine 1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012 - Conditions: Human Immunodeficiency Virus; STDs; Hepatitis, Viral, Human
Intervention: Behavioral: Tailored Cue Cards
Sponsors: RTI International; RTI International; National Institute on Drug Abuse (NIDA)
Active, not recruiting - verified August 2011 - Condition: Herpes Zoster
Interventions: Biological: Zoster Vaccine Live; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: HIV; HIV Infections
Intervention: Drug: Valacyclovir
Sponsors: University of Washington; University of Washington
Recruiting - verified November 2011 - Condition: HSV-2
Interventions: Drug: AIC316; Drug: AIC316; Drug: AIC316; Drug: AIC316; Drug: Placebo
Sponsors: AiCuris GmbH & Co.KG; AiCuris GmbH & Co.KG; FHI 360
Completed - verified October 2010 - Conditions: Liver Metastases; Primary Liver Cancers
Intervention: Biological: administration of rRp450 into the hepatic artery
Sponsors: Massachusetts General Hospital; Kenneth K. Tanabe, MD; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Sexually Transmitted Infections; HIV Infections
Intervention:
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center; Mississippi State Department of Health
Suspended - verified July 2010 - Conditions: Hepatitis C Virus Infection; Infection; Herpesvirus 2, Human
Intervention: Drug: Valacyclovir
Sponsors: G.V. (Sonny) Montgomery VA Medical Center; G.V. (Sonny) Montgomery VA Medical Center
Active, not recruiting - verified November 2011 - Condition: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
Intervention: Drug: HF10
Sponsors: Takara Bio Inc.; Takara Bio Inc.
Recruiting - verified October 2011 - Condition: Herpes Simplex
Intervention: Other: Neem Based External Application Cream
Sponsors: Southern California University of Health Sciences; Southern California University of Health Sciences
Completed - verified November 2011 - Conditions: Herpes Simplex Virus; Neonatal Sepsis
Intervention: Drug: Acyclovir
Sponsors: Duke University; Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2012 - Condition: Herpes Zoster in Autologous Hematopoietic Stem Cell Transplantation Recipients
Interventions: Biological: Herpes Zoster Vaccine 1437173A; Biological: Placebo vaccine (saline)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Conditions: Chickenpox; Herpes Zoster
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Herpes Labialis; Herpes Simplex Virus
Interventions: Drug: Glutamine; Drug: Glycine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified December 2011 - Condition: Non-CNS Solid Tumors
Intervention: Biological: HSV1716
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; FDA Office of Orphan Products Development
Recruiting - verified March 2012 - Condition: Herpes Labialis
Intervention: Drug: Famciclovir
Sponsors: Novartis; Novartis Pharmaceuticals
Completed - verified May 2012 - Condition: Viral Infections
Intervention:
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital
Recruiting - verified July 2011 - Condition: Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
Interventions: Biological: GSK Biological's investigational vaccine 209762; Biological: M-M-R® II (Merck and Co); Biological: Varivax®; Biological: Havrix®; Biological: Prevnar®
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified November 2011 - Conditions: Herpes Zoster; HIV Infections
Interventions: Biological: Zoster Vaccine Live; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group; Merck
Completed - verified May 2012 - Condition: Herpes Simplex
Intervention: Drug: acyclovir sodium
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Cancer Pain
Intervention: Biological: NP2
Sponsors: Diamyd Inc; Diamyd Inc
Active, not recruiting - verified October 2011 - Conditions: HSV-2; HIV; HIV Infections
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; GlaxoSmithKline
Recruiting - verified August 2011 - Conditions: Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
Interventions: Biological: AdV-tk; Drug: Valacyclovir
Sponsors: Advantagene, Inc.; Advantagene, Inc.
Active, not recruiting - verified February 2012 - Conditions: Bacterial Vaginosis; Herpes Simplex Virus Type II
Interventions: Drug: Placebo; Drug: Valacyclovir
Sponsors: University of Pittsburgh; University of Pittsburgh
Withdrawn - verified February 2012 - Conditions: Pancreatic Adenocarcinoma; Pancreatic Cancer
Interventions: Biological: AdV-tk; Drug: Valacyclovir
Sponsors: Advantagene, Inc.; Advantagene, Inc.
Active, not recruiting - verified September 2011 - Condition: Neuropathic Pain
Intervention: Other: Geranium oil
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center
Completed - verified May 2012 - Conditions: Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma
Interventions: Biological: AdV-tk; Drug: Valacyclovir
Sponsors: Advantagene, Inc.; Advantagene, Inc.
Active, not recruiting - verified February 2012 - Conditions: Measles-Mumps-Rubella-Varicella Vaccine; Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses.
Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136); Biological: ProQuad®; Biological: Havrix®; Biological: Prevnar®
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Pain
Intervention: Drug: oxymorphone IV
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; Endo Pharmaceuticals
Completed - verified July 2011 - Condition: Atopic Dermatitis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Atopic Dermatitis and Vaccinia Network
Active, not recruiting - verified October 2011 - Conditions: Genital Herpes; HIV Infections
Interventions: Drug: valacyclovir; Drug: acyclovir
Sponsors: University of Washington; University of Washington; GlaxoSmithKline
Active, not recruiting - verified December 2011 - Condition: Atopic Dermatitis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified October 2011 - Condition: Genital Herpes
Intervention: Drug: acyclovir
Sponsors: University of Washington; University of Washington; National Institutes of Health (NIH)
Completed - verified March 2012 - Condition: Genital Herpes
Interventions: Drug: acyclovir; Drug: acyclovir
Sponsors: University of Washington; University of Washington; National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting - verified September 2011 - Conditions: Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
Interventions: Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate; Biological: Routine pediatric vaccines
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Completed - verified June 2011 - Condition: Bacterial Vaginosis
Intervention: Drug: Metronidazole
Sponsors: University of Pittsburgh; University of Pittsburgh
Completed - verified August 2011 - Condition: Bipolar Disorder
Interventions: Drug: Valacyclovir; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; Stanley Medical Research Institute
Active, not recruiting - verified January 2011 - Condition: Sarcoma
Intervention: Drug: liposomal daunorubicin citrate
Sponsors: AIDS Malignancy Clinical Trials Consortium; AIDS Malignancy Clinical Trials Consortium; National Cancer Institute (NCI)
Terminated - verified December 2011 - Condition: Pancreatic Cancer
Intervention: Genetic: OncoVEX GM-CSF modified herpes-simplex 1 virus
Sponsors: BioVex Limited; BioVex Limited
Completed - verified August 2011 - Condition: Herpesvirus 8, Human
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Completed - verified June 2011 - Condition: Genital Herpes
Interventions: Drug: Famciclovir; Drug: Valacyclovir; Drug: Placebo matching famciclovir; Drug: Placebo matching valacyclovir
Sponsors: Novartis; Novartis Pharmaceuticals
Completed - verified June 2011 - Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified September 2011 - Condition: Recurrent Genital Herpes (RGH)
Intervention: Drug: Famciclovir
Sponsors: Novartis; Novartis
Completed - verified April 2012 - Conditions: Relapsed or Refractory Severe Aplastic Anemia; Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath(Registered Trademark))
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Herpes Simplex
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 2011 - Condition: Genital Herpes
Intervention: Drug: Famciclovir
Sponsors: Novartis; Novartis
Completed - verified April 2012 - Condition: Giant Lymph Node Hyperplasia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: BufferGel; Drug: PRO 2000/5 Gel; Drug: Placebo gel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); HIV Prevention Trials Network
Completed - verified April 2012 - Condition: Epstein-Barr Virus Infections
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: Herpes Simplex
Interventions: Drug: Acyclovir; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified October 2009 - Condition: Herpes Simplex
Interventions: Drug: Acyclovir; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified November 2009 - Conditions: Herpes Zoster; Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine; Biological: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Merck; National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified March 2012 - Conditions: HIV Infections; Chickenpox
Intervention: Biological: Varicella Virus Vaccine (Live)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed - verified May 2012 - Conditions: Herpes Simplex; HIV Infections
Interventions: Drug: Trifluridine; Drug: Bacitracin zinc/Polymyxin B sulfate
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Glaxo Wellcome
Completed - verified March 2012 - Conditions: Herpes Simplex; HIV Infections
Interventions: Drug: Vidarabine; Drug: Acyclovir; Drug: Foscarnet sodium
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified March 2012 - Condition: HIV Infections
Intervention: Drug: Foscarnet sodium
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified March 2012 - Conditions: Cytomegalovirus Retinitis; HIV Infections
Intervention: Drug: Foscarnet sodium
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified March 2012 - Conditions: Cytomegalovirus Retinitis; HIV Infections
Interventions: Drug: Zidovudine; Drug: Acyclovir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified March 2012
 |
Join Clinical Trials in Aurora, Colorado |
